Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study

(2012) Nrupen A. Bhavsar et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease

(2012) Thomas L. Nickolas et al.   KIDNEY INTERNATIONAL

Lipocalin 2 is essential for chronic kidney disease progression in mice and humans

(2010) Amandine Viau et al.   JOURNAL OF CLINICAL INVESTIGATION

Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation

(2010) Jolanta Malyszko et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

(2009) D. Bolignano et al.   Clinical Journal of the American Society of Nephrology

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage

(2008) Davide Bolignano et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography

(2008) Wang Ling et al.   NEPHRON CLINICAL PRACTICE

Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2–4 Chronic Kidney Disease

(2008) Jolanta Malyszko et al.   RENAL FAILURE